Genmab

	30/4 19:33 af Vitus	Godt spørgsmål, men jeg er overbevist om, at mange har mistet tålmodigheden !
	30/4 18:47 af lahn1	Hvorlænge skal man havde været aktionær i Gmab for at kunne kalde sig for En Tålmodig Invester ?
	30/4 16:21 af E L	TECVAYLI available in Spain from may1 (link)
	30/4 15:14 af E L	New trial - Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy (HexaBody-OX40) (link)
	30/4 15:12 af E L	it seems no patients were recruited yet, so the costs should be limited
	30/4 15:11 af E L	the new Endometrial Cancer trial with GEN1046 will not continue; due to [Enrollment challenged by availability of other treatment options] (link)
	30/4 13:41 af E L	Bio-Techne Corporation (NASDAQ: TECH) today announced the appointment of Dr. Judith Klimovsky to serve as an independent director on the Company's Board of Directors (link) -Bio-Techne is a leading supplier of high quality and innovative tools for Life Science Research, Therapeutic Manufacturing and Clinical Diagnostics.
	30/4 13:40 af E L	no, i don't. would be fun indeed to look at these same analysts forecasts for that
	30/4 13:18 af GeorgeBest	Thanks E L. Do you know how the forecasters see the market share split between epco versus glofi/monesu? 50/50?
	30/4 13:14 af Raun	Hvor er det da ved at være pinligt for Jyske Bank.... - Hold nu op, hvor har de gentaget sig selv mange gange igennem de seneste måneder.... - De må have et ordentlig læs aktier de meget gerne vil af med :-)
	30/4 13:01 af lahn1	Det skrev Jyske også for 3 mdr siden
	30/4 12:51 af w	jyske undrer sig også over fald ovenpå positive nyheder
	30/4 12:43 af royal	KYSO. att.: Helge: "Den tålmodige investor II" bør handle om Genmab investorere. :-)
	30/4 12:40 af royal	"Vi anbefaler, at investorerne stille og roligt begynder at stige ombord på toget, inden det kører." Zzzzzzzzzzzzzzzzzzz
	30/4 12:09 af E L	jyskebank monthly (link)
	30/4 11:56 af lahn1	wise guy ;-)
	30/4 11:38 af E L	the strength of the competition will greatly affect epco sales, it will be a battle
	30/4 11:37 af E L	Take your pick ;-)
	30/4 11:36 af E L	Jefferies analysts previously predicted Epkinly could reach about $2.75 billion in peak sales.
	30/4 11:36 af E L	Drug: Epcoritamab Companies: AbbVie and Genmab Used for: Lymphoma Est. 2028 sales: $1.7 billion (link)
	30/4 11:34 af E L	Sydbank epcoritamab He estimates the new drug’s annual peak sales potential at USD 3.5bn.(link)
	30/4 11:33 af E L	Due to Epkinly's tremendous efficacy, analysts at SVB Securities think that the drug could reach peak annual sales of $3 billion in the U.S. (link)
	30/4 11:33 af E L	'GlobalData’s consensus forecast forecasts that Epkinly will achieve blockbuster status by 2027, with global sales expected to exceed $1.9bn by 2029.' from may last year (link)
	30/4 11:21 af GeorgeBest	Thanks E L 09:48. Can you also see what’s the forecast for epcoritamab is by 2030?

	30/4 10:34 af Riis7	Og fcm:-)
	30/4 10:32 af Bullish	OB og Genmab har noget til fælles for tiden..
	30/4 09:51 af E L	i am sure we will still all be here in 2030 to see if that comes true, whilst complaining about the share price ;-)
	30/4 09:49 af E L	(link)
	30/4 09:48 af E L	Tivdak seems to go a little bit under the radar, but 'According to GlobalData’s patient-based forecast, Tivdak is forecast to generate sales of $1.4bn in the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada) by 2030'
	30/4 09:47 af E L	This full approval is the minimum requirement to continue with Tivdak and therefore an important step. It will depend on how much new owner Pfizer sees in the drug, but the EMA application and current conversations with regulators to continue also in head and neck cancer bode well for now.
	30/4 09:44 af w	Komplet uforståeligt at den kan falde på en godkendelse, der iøvrigt kom før tid
	30/4 09:44 af royal	Lige før man håber på et dårligt Q1 på torsdag.
	30/4 09:32 af Vitus	Vor herre bev……
	30/4 09:18 af w	Alt er indregnet;)
	30/4 09:17 af Vitus	Betyder det noget…..
	30/4 09:03 af lahn1	Dejligt med endnu en god nyhed :-)
	30/4 08:59 af E L	nicely on time, PDUFA goal date was May 9
	30/4 08:08 af JKY_VH	Argh, det er vel ikke så stor en overraskelse, at det slår bunden ud af aktien;-)
	30/4 06:58 af royal	Spændende hvad det koster på kursen. :-)
	30/4 06:56 af transalp	Go morgen.. :)
	30/4 06:51 af ProInvestorNEWS	Genmab og partner henter fuld amerikansk godkendelse til livmoderhalskræftmiddel (link)
	30/4 06:36 af Stroka	og tak for en god nyhed. :-)
	30/4 06:36 af bibob	God morgen. :-)
	30/4 06:36 af Stroka	God morgen :-)
	30/4 06:08 af Helge Larsen/PI-redaktør	Godmorgen :-)
	30/4 05:34 af JKY_VH	Tak for det og god morgen;-)
	30/4 05:22 af Budweis	(link)
	30/4 05:20 af Budweis	TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
	29/4 22:49 af Solsen	Ok
	29/4 22:33 af w	Det er måske gennem Gamida cell han har sin viden. Her er han medical director. De har nogle celle terapiforsøg kørende i MM med noget cd38 kombination